January 5th, 2010
Tuesday News Roundup: Catheter Ablation of VT, TRITON-TIMI 38 Substudy, Benefits of Exercise, & More
Larry Husten, PHD
The VTACH trial of catheter ablation of VT prior to ICD implantation has been published in the Lancet. You can find summaries of the trial at Cardiosource, TheHeart.Org and MedPage Today.
The TRITON-TIMI 38 cost-effectiveness substudy of prasugrel vs. clopidogrel in ACS patients appears in Circulation. Lilly also issued a press release.
Two articles in the Wall Street Journal focus on the benefits of exercise:
The Hidden Benefits of Exercise: Even Moderate Physical Activity Can Boost the Immune System and Protect Against Chronic Diseases, by Laura Landro
Why You Should Step Up Yourk Workout, by Kevin Helliker (Article about Paul Williams, who has ignited controversy because of his strong emphasis on progressively greater health benefits with increased workloads of exercise.).
The Seeking Alpha blog discusses Pfizer’s Apo-A1 Milano flop, in which “Pfizer gets $0.01 billion back from its $1.25 billion investment.”
NEJM Journal Watch — Recent Cardiology Articles- Should Blood Pressure Targets Differ for Frail and Nonfrail Adults?
- Sudden Cardiac Death in the U.S.: 20-Year Trends
- Oral Semaglutide Approved to Lower Cardiovascular Risk in High-Risk Patients with Type 2 Diabetes
- Covid-19 Vaccines Improve Heart Outcomes
- Detecting Atrial Fibrillation After Transient In-Hospital Episodes